Novonordisk.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.
- Website Age
n/a
- Alexa Rank no-data
- Country
Netherlands
- IP Address
52.166.181.85
google ads
HTML SIZE INFORMATION
novonordisk.com has a website text/code ratio of 7.09 %. Search engine crawlers tend to not pick up pages with inadequate content.
IMPORTANT HTML TAGS AND COUNTS
Titles
H1
| No |
Text |
| 1 |
438 we offer0 job opportunities |
H2
| No |
Text |
| 1 |
Our response to covıd-19 |
| 2 |
Our research areas |
| 3 |
Turning scientific ideas into medicines |
| 4 |
Making our medicines accessible and affordable |
| 5 |
Preventing the rise of type 2 diabetes |
H3
| No |
Text |
| 1 |
ımportant safety information about colour change for fiasp® flextouch® and fiasp® penfill® |
H4
| No |
Text |
| 1 |
Our commitment todefeat diabetes |
| 2 |
Who we are |
| 3 |
Novo nordisk websites |
| 4 |
Novo nordisk worldwide |
| 5 |
Shareholder ınformation |
| 6 |
Annual reporting |
| 7 |
Contact quick links |
H5
Text Styling
- STRONG1
- B0
- EM0
- I0
- U0
- CITE0
STRONG
LINK ANALYSIS
Total Link Count: 147
Internal Link Count
: 133
| No |
Text |
Type |
| 1 |
- |
empty |
| 2 |
- |
empty |
| 3 |
Back |
text |
| 4 |
Patients |
text |
| 5 |
Patients |
text |
| 6 |
Type 1 diabetes |
text |
| 7 |
Type 1 diabetes |
text |
| 8 |
Gestational diabetes |
text |
| 9 |
Gestational diabetes |
text |
| 10 |
Diabetes pens and needles support |
text |
| 11 |
Diabetes pens and needles support |
text |
| 12 |
Haemophilia |
text |
| 13 |
Growth disorders and growth hormone pens |
text |
| 14 |
Growth disorders and growth hormone pens |
text |
| 15 |
Disease experience expert panel (DEEP) |
text |
| 16 |
Research & Development |
text |
| 17 |
Research & Development |
text |
| 18 |
Science & innovation |
text |
| 19 |
Science & innovation |
text |
| 20 |
Our scientific approach |
text |
| 21 |
Stem cell research |
text |
| 22 |
R&D facts & figures |
text |
| 23 |
Global R&D centres |
text |
| 24 |
Publications |
text |
| 25 |
Our therapy areas |
text |
| 26 |
Our therapy areas |
text |
| 27 |
Type 1 diabetes |
text |
| 28 |
Type 2 diabetes |
text |
| 29 |
Obesity |
text |
| 30 |
Atherosclerosis |
text |
| 31 |
NASH |
text |
| 32 |
Haemophilia |
text |
| 33 |
Growth disorders |
text |
| 34 |
Partner with us |
text |
| 35 |
Partnering opportunities |
text |
| 36 |
Events & meetings |
text |
| 37 |
Contact us |
text |
| 38 |
Open innovation |
text |
| 39 |
Compound sharing |
text |
| 40 |
Innovation Challenges |
text |
| 41 |
Future science |
text |
| 42 |
Pipeline |
text |
| 43 |
Bioethics |
text |
| 44 |
Bioethics |
text |
| 45 |
Animal ethics |
text |
| 46 |
Clinical trial ethics |
text |
| 47 |
Human biosample ethics |
text |
| 48 |
Stem cell ethics |
text |
| 49 |
Gene technology ethics |
text |
| 50 |
Sustainable business |
text |
External Link Count
: 14
| No |
Text |
Type |
| 1 |
Type 2 diabetes |
text |
| 2 |
Type 2 diabetes |
text |
| 3 |
Obesity |
text |
| 4 |
Obesity |
text |
| 5 |
Partic****ting in our clinical trials |
text |
| 6 |
Clinical trials |
text |
| 7 |
Please visit NovoCare |
text |
| 8 |
- |
image |
| 9 |
- |
image |
| 10 |
- |
image |
| 11 |
- |
image |
| 12 |
- |
image |
| 13 |
Novo Nordisk in the USA |
image |
| 14 |
Novo Nordisk in Denmark |
image |
Nofollow Link Count
: 0
Title Link Count
: 0
WEBSITE SERVER INFORMATION
- Service Provider (ISP)
- Microsoft Corporation
- Hosted IP Address
- 52.166.181.85
- Hosted Country
Netherlands
- Host Region
- North Holland , Amsterdam
- Latitude and Longitude
- 52.3667 : 4.9
WEBSITES USING THE SAME IP ADDRESS